BeStock  
Stocks › COAG

Hemab Therapeutics Holdings COAG

US equityMarket cap rank #3006
$30.59 −$0.52 (-1.67%)
Market closed · Oct 6, 4:10 am ET · Last extended-hours $30.59 0.00%
Open$31.11
Prev close$31.11
Day range$29.76 – $31.11
Volume294.5K
Market cap$1.43B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, not just today’s reading.

Community Sentiment on COAG

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

COAG at a glance

Hemab Therapeutics Holdings (COAG) is trading at $30.59, down 1.67% on the day. Its market value of $1.43B makes it the 3006th largest of the 3132 companies we follow.

Over the past 52 weeks it has traded between $23.00 and $55.42, so it sits 44.8% below the top of that range.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

COAG is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2021-01-04, the strategy has returned 389% (231.1% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated weekly — not a guarantee of future results, and not a BeStock recommendation.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-1.7%
1 week
-7.6%
1 month
-31.1%
3 months
-2.9%
Day range
$29.76$31.11
52-week range
$23.00$55.42

Technical signals

Full technicals →
Trend readStrong downtrend

0 bullish · 4 bearish of 5 signals

IndicatorValueSignal
Price vs 20-day average-17.9%Bearish
Price vs 50-day average-30.7%Bearish
RSI (14)22.4Neutral
MACD (12,26,9)-3.77Bearish
Bollinger band position13%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Key statistics

Bid / Ask$29.80 / $48.63
Average price today$30.52
Volume294.5KAvg (90d) 404.2K
Turnover$8.99M
Turnover rate1.76%of shares outstanding
Volume ratio0.60vs. recent average pace
Day amplitude4.34%
Market cap$1.43B
Float market cap$512.38M
Shares outstanding16.75M
EPS (TTM)-$1.45
P/B3.15
Book value / share$9.73
Earnings yield-0.18%
Net profit (TTM)-$67.55M
Net assets$454.28M
30-day volatility59.2%annualized
Avg daily range (ATR)8.60%of price, 14 days
Max drawdown (1y)-44.3%-44.3% from 1y peak

Quote as of Oct 6, 2026 4:10 am ET. Prices can lag the live tape. This is background information, not a recommendation.

How COAG ranks on BeStock

Market value#3005 of 3131
Closeness to 52-week high#2803 of 3126
Dollar volume today#2163 of 3131

Ranks are among the 3,131 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

COAG stock: common questions

How is Hemab Therapeutics Holdings stock doing today?

$30.59 is the latest print for COAG, a move of -1.67% against yesterday's close of $31.11. Today's low and high so far: $29.76 and $31.11.

How big is Hemab Therapeutics Holdings?

Equity value comes to $1.43B at the current price. By that measure it is number 3006 of the 3132 names in our coverage.

How far is COAG from its yearly high?

The year's floor is $23.00 and the ceiling $55.42. Shares are 44.8% away from that ceiling.

Are there dividends on Hemab Therapeutics Holdings shares?

Our data shows no dividend paid by Hemab Therapeutics Holdings over the trailing twelve months.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on COAG.

Leave a comment

Scroll to Top